efinaconazole nail Jublia
Selected indexed studies
- Onychomycosis: Treatment and prevention of recurrence. (J Am Acad Dermatol, 2019) [PMID:29959962]
- Onychomycosis: a review. (J Eur Acad Dermatol Venereol, 2020) [PMID:32239567]
- Updated Perspectives on the Diagnosis and Management of Onychomycosis. (Clin Cosmet Investig Dermatol, 2022) [PMID:36133401]
_Worker-drafted node — pending editorial review._
Connections
efinaconazole nail Jublia is a side effect of
Sources
- Onychomycosis: Treatment and prevention of recurrence. (2019) pubmed
- Updated Perspectives on the Diagnosis and Management of Onychomycosis. (2022) pubmed
- Onychomycosis: Rapid Evidence Review. (2021) pubmed
- Onychomycosis: a review. (2020) pubmed
- Efinaconazole in Onychomycosis. (2022) pubmed
- Efinaconazole 10% nail solution: a new topical treatment with broad antifungal activity for onychomycosis monotherapy. (2014) pubmed
- Efinaconazole and Tavaborole. (2017) pubmed
- Efinaconazole 10% solution: a comprehensive review of its use in the treatment of onychomycosis. (2024) pubmed
- Treatment Options for Onychomycosis: Efficacy, Side Effects, Adherence, Financial Considerations, and Ethics. (2024) pubmed
- Efinaconazole (Jublia) for the treatment of onychomycosis. (2014) pubmed